Alnylam Pharmace. buy Bank of America Co.
Start price
17.09.25
/
50%
€386.50
Target price
17.09.26
€438.62
Performance (%)
-31.93%
Price
17.04.26
€263.10
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Alnylam Pharmace. is performing very badly with a performance of -31.93%. This prediction currently runs until 17.09.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Alnylam Pharmace. | -4.258% | -4.258% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Bank of America Corporation from $453.00 to $520.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€305.80
12.01.26
12.01.26
€453.72
12.01.27
12.01.27
-13.96%
17.04.26
17.04.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€270.80
11.07.25
11.07.25
€307.48
11.07.26
11.07.26
-2.84%
17.04.26
17.04.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€259.80
14.10.24
14.10.24
€287.94
14.10.25
14.10.25
54.66%
15.10.25
15.10.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€228.50
04.09.24
04.09.24
€277.62
04.09.25
04.09.25
69.02%
05.09.25
05.09.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€222.50
25.06.24
25.06.24
€275.35
25.06.25
25.06.25
24.90%
26.06.25
26.06.25